LUNG CANCER
The better knowledge – the easier fight 27. 11. 2020 15:40 – 16:40
Chairman: MUDr. Gabriela Krákorová, Ph.D.
Clinical Case: Alectinib▼ in the first line setting of ALK+ NSCLC – MUDr. Daniel Krejčí Clinical case of long-term effect of atezolizumab▼ in the first-line treatment of ES-SCLC – MUDr. Marie Drösslerová
Panel Discussion: prof. MUDr. Jana Skřičková, CSc. prof. MUDr. Luboš Petruželka, CSc. prof. MUDr. Miloš Pešek, CSc. doc. MUDr. Milada Zemanová, Ph.D. MUDr. Libor Havel Roche s. r. o., Futurama Business Park Bld F, Sokolovská 685/136f, 186 00 Praha 8, Tel.: +420 220 382 111, www.roche.cz M-CZ-00001164